Close Menu

NEW YORK (GenomeWeb) – CareDx announced today that it plans to sell 2 million shares of its common stock in a public offering and expects to raise about $49 million in proceeds.

The firm has priced the offering at $24.50 per share and has granted the underwriters a 30-day option to purchase up to an additional 300,000 shares. Net proceeds from the offering are expected to be approximately $45.9 million after deducting underwriting discounts and commissions. The offering is expected to close on or about Nov. 16.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.